Related Articles
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy
Impact of copy number variant and single nucleotide polymorphism of the programmed death‑ligand 1 gene, programmed death‑ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non‑small cell lung carcinoma
Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment
Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma
Association of PD‑L1 and ZEB‑1 expression patterns with clinicopathological characteristics and prognosis in oral squamous cell carcinoma